Perfil
Gregory T.
Bates worked as Senior VP-Regulatory Affairs & Quality at XenoPort, Inc. He then worked as Vice President-Regulatory Affairs at ATAI Life Sciences NV from 2019 to 2022.
Bates received his undergraduate degree from the University of California, Berkeley and his doctorate degree from the University of California, Davis.
Antiguos cargos conocidos de Gregory T. Bates.
| Empresas | Cargo | Fin |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | Consejero General | 01/05/2022 |
| XENOPORT, INC. | Consejero General | - |
Formación de Gregory T. Bates.
| University of California, Berkeley | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Empresas privadas | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory T. Bates